Moreover, flow cytometry analysis showed that the percentages of tumor-infiltrating CD3+ T cells and CD69-positive CD8+ T cells were significantly increased after NPTyr-C9AP treatment (Fig. 7d, e, i, j, Supplementary Fig. 28). The gene discussed is CD8A; the disease is neoplasm.